The major biogenic amine metabolites in mood disorders

被引:0
作者
Yang, Jingyi [1 ]
Yuan, Minlan [1 ]
Zhang, Wei [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Psychiat Lab,State Key Lab Biotherapy, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China
[3] Sichuan Univ, Big Data Ctr, Chengdu, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词
mood disorder; major depressive disorder; bipolar disorder; metabolite; biogenic amine; HISTAMINE H-3 RECEPTOR; CREATINE MONOHYDRATE AUGMENTATION; KYNURENINE PATHWAY METABOLITES; DEPRESSIVE-LIKE BEHAVIORS; BIPOLAR DISORDER; GUT MICROBIOTA; DOUBLE-BLIND; ADOLESCENT DEPRESSION; NEUROTROPHIC FACTOR; FEMALE ADOLESCENTS;
D O I
10.3389/fpsyt.2024.1460631
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Mood disorders, including major depressive disorder and bipolar disorder, have a profound impact on more than 300 million people worldwide. It has been demonstrated mood disorders were closely associated with deviations in biogenic amine metabolites, which are involved in numerous critical physiological processes. The peripheral and central alteration of biogenic amine metabolites in patients may be one of the potential pathogeneses of mood disorders. This review provides a concise overview of the latest research on biogenic amine metabolites in mood disorders, such as histamine, kynurenine, and creatine. Further studies need larger sample sizes and multi-center collaboration. Investigating the changes of biogenic amine metabolites in mood disorders can provide biological foundation for diagnosis, offer guidance for more potent treatments, and aid in elucidating the biological mechanisms underlying mood disorders.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders
    Beaulieu, Serge
    Saury, Sybille
    Sareen, Jitender
    Tremblay, Jacques
    Schuetz, Christian G.
    McIntyre, Roger S.
    Schaffer, Ayal
    ANNALS OF CLINICAL PSYCHIATRY, 2012, 24 (01) : 38 - 55
  • [42] Cortical Thickness in Individuals at High Familial Risk of Mood Disorders as They Develop Major Depressive Disorder
    Papmeyer, Martina
    Giles, Stephen
    Sussmann, Jessica E.
    Kielty, Shauna
    Stewart, Tiffany
    Lawrie, Stephen M.
    Whalley, Heather C.
    McIntosh, Andrew M.
    BIOLOGICAL PSYCHIATRY, 2015, 78 (01) : 58 - 66
  • [43] Assessment and treatment of mood disorders in the context of substance abuse
    Tolliver, Bryan K.
    Anton, Raymond F.
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2015, 17 (02) : 181 - 190
  • [44] Personalized medicine: Prediction of disease vulnerability in mood disorders
    Prendes-Alvarez, Stefania
    Nemeroff, Charles B.
    NEUROSCIENCE LETTERS, 2018, 669 : 10 - 13
  • [45] Sex differences in brain metabolites in anxiety and mood disorders
    Pigoni, Alessandro
    Delvecchio, Giuseppe
    Squarcina, Letizia
    Bonivento, Carolina
    Girardi, Paolo
    Finos, Livio
    Crisanti, Camilla
    Balestrieri, Matteo
    D'Agostini, Serena
    Stanley, Jeffrey A.
    Brambilla, Paolo
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2020, 305
  • [46] Bright Light as a Personalized Precision Treatment of Mood Disorders
    Maruani, Julia
    Geoffroy, Pierre Alexis
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [47] Use of ecological momentary assessment in mood disorders research
    Wenze, Susan J.
    Miller, Ivan W.
    CLINICAL PSYCHOLOGY REVIEW, 2010, 30 (06) : 794 - 804
  • [48] Molecular Link between Circadian Rhythmicity and Mood Disorders
    Faltraco, Frank
    Palm, Denise
    Coogan, Andrew
    Simon, Frederick
    Tucha, Oliver
    Thome, Johannes
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (36) : 5692 - 5709
  • [49] Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells
    Bauer, Moises E.
    Teixeira, Antonio L.
    NEUROIMMUNOMODULATION, 2021, 28 (03) : 99 - 107
  • [50] Nutraceuticals in mood disorders: current knowledge and future directions
    Travica, Nikolaj
    Teasdale, Scott
    Marx, Wolfgang
    CURRENT OPINION IN PSYCHIATRY, 2023, 36 (01) : 54 - 59